IGHE and asthma: An alternative and clinically proven approach for atopic severe asthma is the use of the monoclonal antibody to IgE (omalizumab), which reduces circulating IgE and leads to down-regulation of its high affinity receptor FcεR1 on mast cells and basophils [31].